8-K: My Size Faces Nasdaq Delisting Warning Over Bid Price

My Size, Inc. received a notice from Nasdaq regarding non-compliance with the minimum $1.00 bid price requirement, initiating a 180-day compliance period.

Summary

• My Size, Inc. (MYSZ) was notified by Nasdaq Listing Qualifications on March 2, 2026, that it is not in compliance with Nasdaq Listing Rule 5550(a)(2).
• The rule requires listed securities to maintain a minimum bid price of $1.00 per share.
• The non-compliance stems from the company's common stock closing bid price being below $1.00 for 30 consecutive business days prior to the notification date.
• The notification does not immediately affect the listing or trading of MYSZ common stock on the Nasdaq Capital Market.
• The company has 180 calendar days, until August 31, 2026, to regain compliance.
• To regain compliance, the common stock's closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days.
• If compliance is not regained by August 31, 2026, the company may be eligible for an additional 180-day period if it meets other listing requirements.
• Failure to regain compliance after any extended period could lead to Nasdaq's determination to delist the common stock, with an opportunity for appeal.
• The company intends to monitor its stock price and may consider options such as a reverse stock split to regain compliance.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the immediate risk of delisting and the underlying poor stock performance it signifies. While a compliance period exists, the need for a potential reverse stock split often indicates deeper issues.

Negatives

• The company is not in compliance with Nasdaq's minimum bid price requirement of $1.00 per share.
• The stock price has traded below $1.00 for 30 consecutive business days, indicating sustained low market valuation.
• There is a risk of delisting from the Nasdaq Capital Market if compliance is not regained within the specified periods.

Risks

• Failure to regain compliance with Nasdaq's minimum bid price requirement by August 31, 2026, or during any subsequent extension, could lead to the delisting of the company's common stock.
• Delisting could significantly reduce the liquidity and marketability of the company's shares, negatively impacting shareholders.
• The potential implementation of a reverse stock split, while a compliance mechanism, often signals underlying business challenges and can be perceived negatively by investors, potentially leading to further stock price volatility or decline.

Future Outlook

The company intends to monitor the closing bid price of its common stock and may consider implementing available options, such as a reverse stock split, to regain compliance with Nasdaq's minimum bid price requirement.

Management Comments

• "The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider implementing available options, including, but not limited to, implementing a reverse stock split of its outstanding securities, to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules."

Industry Context

StockSavvy.ai notes that receiving a minimum bid price deficiency notice is a common occurrence for smaller-cap companies, particularly those in growth or development stages. While a reverse stock split is a standard mechanism to address such issues and maintain listing, it often reflects underlying challenges in market valuation and investor confidence, which can be a concern for the broader industry segment.

Comparison to Industry Standards

• This situation is common among micro-cap technology companies that may experience periods of low trading volume or market disinterest, leading to share prices falling below exchange minimums.
• Many companies in similar positions, such as those in the early-stage tech or biotech sectors, have faced similar Nasdaq notices and often resort to reverse stock splits as a primary strategy to maintain listing.
• The 180-day compliance period is standard for Nasdaq minimum bid price deficiencies, aligning with the typical timeframe provided to other listed entities.

Stakeholder Impact

• Shareholders face potential dilution if a reverse stock split is implemented, and a significant risk of reduced liquidity and marketability if the stock is ultimately delisted from Nasdaq.
• Investor confidence may be negatively impacted by the delisting notice and the company's inability to maintain minimum listing standards.

Next Steps

• Monitor the closing bid price of the common stock.
• Consider implementing available options, such as a reverse stock split, to regain compliance.
• Regain compliance with Nasdaq Listing Rule 5550(a)(2) by August 31, 2026, by achieving a closing bid price of at least $1.00 for 10 consecutive business days.

Key Dates

Recommendation

The company's failure to meet Nasdaq's minimum bid price requirement signals significant underlying challenges and poses a material risk of delisting. While a compliance period exists, the potential need for a reverse stock split often indicates a lack of fundamental strength and can lead to further erosion of shareholder value and liquidity concerns. Investors should consider selling to mitigate further downside risk.

Keywords

My Size Inc, MYSZ, Nasdaq, Delisting Notice, Minimum Bid Price, Compliance, Reverse Stock Split, SEC Filing, 8-K